Home Overview Press Room Blog Publications For Students about us
Search

The Latest from Biopolitical Times

Genetic Crossroads
September 26th, 2007

They Really Mean EVERYBODY into the Pool
by Osagie Obasogie
September 21st, 2007

A small uproar is brewing in the UK after news that the country's criminal forensic database contains the DNA of a 7-month-old baby girl.

Women's Mags Do Surrogacy
by Marcy Darnovsky
September 20th, 2007

Two massive-circulation women's lifestyle magazines - Glamour and Marie Claire - featured articles about contract pregnancy in their August issues.

CIRM's New President: The Good and the Bad
by Jesse Reynolds
September 17th, 2007

The new president of the California stem cell agency brings a diverse set of skills to the table. But Alan Trounson's record as a businessman and advocate is worth a close look.

Everybody into the Pool
by Jamie D. Brooks
September 10th, 2007

It's been confirmed: Collecting arrestees' DNA - as opposed to those convicted of serious violent crimes - exacerbates the racism inherent in criminal justice systems. And how should we combat this? "Collect the DNA of everyone in the U.K.," says Lord Justice Sedley, one of England's most experienced appeal court judges.

ISSCR Enters Local Politics
by Jesse Reynolds
September 7th, 2007

Why would George Daley, the president of an international scientific organization and a top researcher at Harvard, take the time to write a letter to the supervisors of a rural California county? Let's look at some details.

New Technologies, Old Prejudices
by Marcy Darnovsky
August 29th, 2007

Sex selection in China is driven by a combination of traditional preference for sons and strict government policy that limits many couples to one child. An additional key factor is the availability of prenatal screening technology.

The Empire Strikes Back
by Osagie Obasogie
August 28th, 2007

One would hope and expect that Jolee Mohr's recent death during a gene therapy clinical trial would give pause to the field's researchers as well as the multi-billion dollar clinical trial industry. But the response has been surprisingly defiant.


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760